Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Chloride and Sodium Acetate IV Fluids in Acute Stroke Patients
NCT05869565Phase 3Unknown
- Sponsor
- Aga Khan University
- Start
- Feb 2023
- Primary completion
- Feb 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sodium acetate ringer's injection in acute stroke (4 arms), sponsored by Aga Khan University. Primary endpoints: Persistent hyperchloremia at 72 hours and Acute Kidney Injury at 72 hours. Status: unknown.
02
Drugs
sodium acetate ringer's injection
03
Conditions
acute stroke
Beyond the preview
Go deeper on NCT05869565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05869565.